ADX10059 as a Monotherapy in Patients With Gastroesophageal Reflux (GERD)

Clinical trial NCT00820079 · COMPLETED

Trial details

NCT number: NCT00820079
Sponsor: Addex Pharma S.A.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastroesophageal Reflux

Start date: 2008-12-01
Primary completion: 2009-10-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.